CDKN2A mutations in malignant melanoma: Who should we be screening?

被引:0
|
作者
Ung-Juurlink, C [1 ]
From, L [1 ]
Lassam, N [1 ]
机构
[1] Univ Toronto, Toronto, ON, Canada
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:79 / 79
页数:1
相关论文
共 50 条
  • [21] CDKN2A mutations in Spanish cutaneous malignant melanoma families and patients with multiple melanomas and other neoplasia
    Ruiz, A
    Puig, S
    Malvehy, J
    Lázaro, C
    Lynch, M
    Gimenez-Arnau, AM
    Puig, L
    Sánchez-Conejo, J
    Estivill, X
    Tel, TC
    [J]. JOURNAL OF MEDICAL GENETICS, 1999, 36 (06) : 490 - 493
  • [22] Germline CDKN2A mutations in Brazilian patients of hereditary cutaneous melanoma
    Ribeiro de Avila, Alexandre Leon
    Victorino Krepischi, Ana Cristina
    Moredo, Luciana Facure
    Marques Aguiar, Talita Ferreira
    da Silva, Felipe Carneiro
    Soares de Sa, Bianca Costa
    de Nobrega, Amanda Franca
    Waddington Achatz, Maria Isabel
    Duprat, Joao Pedreira
    Landman, Gilles
    Carraro, Dirce Maria
    [J]. FAMILIAL CANCER, 2014, 13 (04) : 645 - 649
  • [23] Screening for tumour suppressor p16(CDKN2A) germline mutations in Israeli melanoma families
    Yakobson, EA
    Zlotogorski, A
    Shafir, R
    Cohen, M
    Icekson, M
    Landau, M
    Brenner, S
    Usher, S
    Peretz, H
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 1998, 36 (08) : 645 - 648
  • [24] Germline CDKN2A mutations in Brazilian patients of hereditary cutaneous melanoma
    Alexandre Leon Ribeiro de Ávila
    Ana Cristina Victorino Krepischi
    Luciana Facure Moredo
    Talita Ferreira Marques Aguiar
    Felipe Carneiro da Silva
    Bianca Costa Soares de Sá
    Amanda França de Nóbrega
    Maria Isabel Waddington Achatz
    João Pedreira Duprat
    Gilles Landman
    Dirce Maria Carraro
    [J]. Familial Cancer, 2014, 13 : 645 - 649
  • [25] Germline CDKN2A mutations are rare in child and adolescent cutaneous melanoma
    Berg, P
    Wennberg, AM
    Tuominen, R
    Sander, B
    Rozell, BL
    Platz, A
    Hansson, J
    [J]. MELANOMA RESEARCH, 2004, 14 (04) : 251 - 255
  • [26] NRAS hypermutability in familial melanoma with CDKN2A mutations - Cause and effect?
    Kraemer, KH
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (11) : 768 - 769
  • [27] Familial melanoma, pancreatic cancer and germline CDKN2A mutations.
    Goldstein, AM
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 73 (05) : 230 - 230
  • [28] Efficacy of novel melanoma treatments in metastatic melanoma patients with germline CDKN2A mutations
    Helgadottir, Hildur
    Ghiorzo, Paola
    van Doorn, Remco
    Puig, Susana
    Levin, Max
    Kefford, Richard
    Queirolo, Paola
    Pastorino, Lorenza
    Lauss, Martin
    Olsson, Hakan
    Hoiom, Veronica
    Jonsson, Goran
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2019, 17
  • [29] Familial melanoma; CDKN2A and beyond
    Gruis, NA
    van der Velden, PA
    Bergman, W
    Frants, RR
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS, 1999, 4 (01) : 50 - 54
  • [30] CDKN2A and BAP1 germline mutations predispose to melanoma and mesothelioma
    Betti, M.
    Aspesi, A.
    Biasi, A.
    Casalone, E.
    Ferrante, D.
    Ogliara, P.
    Gironi, L. C.
    Giorgione, R.
    Farinelli, P.
    Grosso, F.
    Libener, R.
    Rosato, S.
    Turchetti, D.
    Maffe, A.
    Casadio, C.
    Ascoli, V.
    Dianzani, C.
    Colombo, E.
    Piccolini, E.
    Pavesi, M.
    Miccoli, S.
    Mirabelli, D.
    Bracco, C.
    Righi, L.
    Boldorini, R.
    Papotti, M.
    Matullo, G.
    Magnani, C.
    Pasini, B.
    Dianzani, I.
    [J]. CANCER LETTERS, 2016, 378 (02) : 120 - 130